Glipizide Tablets 2.5mg (NDC 72888-115-01)
Glipizide Tablet
Product Images NDC 52817-385
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 52817-385). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Trupharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Glipizide Tablets 2.5mg (NDC 72888-115-05)
Each tablet contains 2.5 mg of glipizide, a medication used to treat diabetes. The recommended dosage and use can be found in the accompanying prescribing information. The tablets should be stored at a temperature between 20°C to 25°C (68°F to 77°F), with excusions permitted to 15°C to 30°C (59°F to 86°F). They should be dispensed in a tightly closed container with a child resistant closure. It is important to keep this medication out of the reach of children. The tablets are distributed by TruPharma LLC in Tampa, FL and manufactured by Rubicon Research Private Limited in India. The manufacturing license number is KD-682.*
Chemical Structure (Glipizide Tabs Usp Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
